Table 1: Clinical and Viral Backgrounds of Patients in Each Three Groups.
Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; MBL,Mannose binding lectin. Note: Comparisons of continuous variables such as ALT, AST, platelet and HBV-DNA count among three groups were made by the Kruskal-Wallis Test, and P < 0.05 was accepted assignificant.
| Groups | Group 1 Active Hepatitis B (n:30) | Group 2 Inactive Hepatitis B (n:20) | Group 3 control (n:21) | p |
| Sex(M:F) | 16/14 | 8/12 | 11/10 | 0.621 |
| Age, years old(mean±SD) | 45±14.1 | 41.8±10.9 | 45.6±12.7 | 0.50 |
| Serum AST(IU/L), (mean±SD) | 61±55.5 | 26.9±19.8 | 22.6±8.8 | <0.001 |
| Serum ALT (IUL) (mean±SD) | 86.8±83.5 | 31.5±29.8 | 22.4±11.9 | <0.001 |
| Platelet(×103/L), (mean) | 177.500 | 211.250 | 240.750 | 0.002 |
| HBeAg(negative), N(%) | 26(86.7) | 20(100) | 21(100) | 0.058 |
| HBV DNA titer, mean (IU/mL) | 1.471.683 | 504.9 | 0.0 | <0.001 |
| MBl ng/ml, (mean/SD) | 2857.3±2040.03 | 2463.9±1915.4 | 1865.04±265.6 | 0.344 |